Bright Minds Biosciences (DRUG) EPS (Basic) (2023 - 2026)
Bright Minds Biosciences' (DRUG) quarterly EPS (Basic) came in at $0.01 in Q4 2024, up 101.79% YoY from $0.0 in Q1 2024, and down 84.7% on a QoQ basis from $0.04 in Q2 2024.
Analysis
Bright Minds Biosciences (DRUG) EPS (Basic) (2023 - 2026) Analysis & Trends
Bright Minds Biosciences (DRUG) has 2 years of EPS (Basic) data on file, last reported at $0.01 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 0.18 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -0.06 |
| 10 | Bright Minds Biosciences | 458.56 Mn | 236.02 Mn | - | -0.55 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.55 |
| Mar 31, 2026 | -1.39 |
| Dec 31, 2025 | -0.87 |
| Sep 30, 2025 | -1.43 |
| Jun 30, 2025 | 0.96 |
| Mar 31, 2025 | 0.54 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | -0.48 |
| Jun 30, 2024 | 0.04 |
| Mar 31, 2024 | 0.34 |
| Dec 31, 2023 | -0.33 |
| Sep 30, 2023 | -1.48 |
| Jun 30, 2023 | -0.44 |